RU2010141064A - METHOD FOR TREATING PAPILLOMAVIRUS INFECTIONS IMPLEMENTED THROUGH INTERLEUKIN INDUCTION - 18 - Google Patents

METHOD FOR TREATING PAPILLOMAVIRUS INFECTIONS IMPLEMENTED THROUGH INTERLEUKIN INDUCTION - 18 Download PDF

Info

Publication number
RU2010141064A
RU2010141064A RU2010141064/15A RU2010141064A RU2010141064A RU 2010141064 A RU2010141064 A RU 2010141064A RU 2010141064/15 A RU2010141064/15 A RU 2010141064/15A RU 2010141064 A RU2010141064 A RU 2010141064A RU 2010141064 A RU2010141064 A RU 2010141064A
Authority
RU
Russia
Prior art keywords
alloferon
injections
course
inducer
interleukin
Prior art date
Application number
RU2010141064/15A
Other languages
Russian (ru)
Other versions
RU2482866C2 (en
Inventor
Герман Петрович Беккер (RU)
Герман Петрович Беккер
Илья Владимирович Духовлинов (RU)
Илья Владимирович Духовлинов
Борис Алексеевич Никонов (RU)
Борис Алексеевич Никонов
Original Assignee
Общество с ограниченной ответственностью "Аллоферон" (RU)
Общество с ограниченной ответственностью "Аллоферон"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество с ограниченной ответственностью "Аллоферон" (RU), Общество с ограниченной ответственностью "Аллоферон" filed Critical Общество с ограниченной ответственностью "Аллоферон" (RU)
Priority to RU2010141064/15A priority Critical patent/RU2482866C2/en
Publication of RU2010141064A publication Critical patent/RU2010141064A/en
Application granted granted Critical
Publication of RU2482866C2 publication Critical patent/RU2482866C2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

1. Способ лечения инфекций, вызванных вирусами папилломы человека, реализуемый через индукцию интерлейкина-18, состоящий в том, что в качестве индуктора используют лекарственные препараты на основе пептида аллоферона, вводимые до или во время, или после механического удаления папилломных образований любого типа. ! 2. Способ по п.1, отличающийся тем, что в качестве индуктора используют инъекции препарата «Аллокин-альфа лиофилизат для приготовления раствора для подкожного введения», курсом из 3 инъекций с интервалом 1 день между инъекциями, причем курс может повторяться. ! 3. Способ по п.1, отличающийся тем, что в качестве индуктора используют суппозитории на основе аллоферона. ! 4. Способ по п.1, отличающийся тем, что в качестве индуктора используют мази, содержащие аллоферон. 1. A method of treating infections caused by human papillomaviruses, realized through the induction of interleukin-18, which consists in the use of drugs based on alloferon peptide, introduced before or during, or after mechanical removal of papillomaviruses of any type. ! 2. The method according to claim 1, characterized in that, as an inducer, injections of the drug "Allokin-alpha lyophilisate for the preparation of a solution for subcutaneous administration" are used, a course of 3 injections with an interval of 1 day between injections, and the course may be repeated. ! 3. The method according to claim 1, characterized in that suppositories based on alloferon are used as an inductor. ! 4. The method according to claim 1, characterized in that as an inducer use ointments containing alloferon.

Claims (4)

1. Способ лечения инфекций, вызванных вирусами папилломы человека, реализуемый через индукцию интерлейкина-18, состоящий в том, что в качестве индуктора используют лекарственные препараты на основе пептида аллоферона, вводимые до или во время, или после механического удаления папилломных образований любого типа.1. A method of treating infections caused by human papillomaviruses, realized through the induction of interleukin-18, which consists in the use of drugs based on alloferon peptide, introduced before or during, or after mechanical removal of papillomaviruses of any type. 2. Способ по п.1, отличающийся тем, что в качестве индуктора используют инъекции препарата «Аллокин-альфа лиофилизат для приготовления раствора для подкожного введения», курсом из 3 инъекций с интервалом 1 день между инъекциями, причем курс может повторяться.2. The method according to claim 1, characterized in that, as an inducer, injections of the drug "Allokin-alpha lyophilisate for the preparation of a solution for subcutaneous administration" are used, a course of 3 injections with an interval of 1 day between injections, and the course may be repeated. 3. Способ по п.1, отличающийся тем, что в качестве индуктора используют суппозитории на основе аллоферона.3. The method according to claim 1, characterized in that suppositories based on alloferon are used as an inductor. 4. Способ по п.1, отличающийся тем, что в качестве индуктора используют мази, содержащие аллоферон. 4. The method according to claim 1, characterized in that as an inducer use ointments containing alloferon.
RU2010141064/15A 2010-10-07 2010-10-07 Method of treating papilloma viral infections implemented through interleukin-18 induction RU2482866C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2010141064/15A RU2482866C2 (en) 2010-10-07 2010-10-07 Method of treating papilloma viral infections implemented through interleukin-18 induction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2010141064/15A RU2482866C2 (en) 2010-10-07 2010-10-07 Method of treating papilloma viral infections implemented through interleukin-18 induction

Publications (2)

Publication Number Publication Date
RU2010141064A true RU2010141064A (en) 2012-04-20
RU2482866C2 RU2482866C2 (en) 2013-05-27

Family

ID=46032150

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2010141064/15A RU2482866C2 (en) 2010-10-07 2010-10-07 Method of treating papilloma viral infections implemented through interleukin-18 induction

Country Status (1)

Country Link
RU (1) RU2482866C2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2560689C2 (en) * 2013-09-06 2015-08-20 Общество с ограниченной ответственностью "Аллоферон" Method of complex therapy of pre-invasive and invasive cervical cancer
RU2014136096A (en) * 2014-09-05 2016-03-27 Общество с ограниченной ответственностью "Аллоферон" MEDICINAL PRODUCT FOR TREATMENT AND PREVENTION OF DISEASES OF UPPER AND LOWER RESPIRATORY WAYS OF VARIOUS ETHIOLOGY, ITS APPLICATION AND METHOD OF TREATMENT ON ITS BASIS
RU2667128C2 (en) * 2016-12-29 2018-09-14 Герман Петрович Беккер Composition for preparation of anti-tumor medication and method for preparation of anti-tumor medication based on it
WO2022015194A1 (en) * 2020-07-15 2022-01-20 Герман Петрович БЕККЕР Antiviral suppository formulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0323965D0 (en) * 2003-10-13 2003-11-19 Glaxosmithkline Biolog Sa Immunogenic compositions

Also Published As

Publication number Publication date
RU2482866C2 (en) 2013-05-27

Similar Documents

Publication Publication Date Title
EA201991174A1 (en) COMBINATION OF TWO ANTIVIRAL DRUGS FOR TREATMENT OF HEPATITIS C
NZ603200A (en) Peptides and their use
PH12015500361A1 (en) Methods for the treatment of hepatitis b and hepatitis d infections
MX2019007779A (en) Method of treating or reducing efp.
MX2012008652A (en) Therapies for treating hepatitis c virus infection.
RU2010141064A (en) METHOD FOR TREATING PAPILLOMAVIRUS INFECTIONS IMPLEMENTED THROUGH INTERLEUKIN INDUCTION - 18
EA201491258A1 (en) Self-flashing catheters
NZ703514A (en) Fviii peptides for immune tolerance induction and immunodiagnostics
MX2015013115A (en) Novel dosing regimens of celgosivir for the treatment of dengue.
IN2014DN05784A (en)
RU2012123182A (en) METHOD FOR CORRECTION OF MENTAL STATE OF PATIENTS AND ANTIOXIDANT STATUS IN ORGANIC DISORDER OF PERSONALITY
RU2013141056A (en) METHOD FOR COMPREHENSIVE THERAPY OF PRE-INVASIVE AND INVASIVE CERVICAL CANCER
UA80369U (en) Method for treating multiresistant pulmonary tuberculosis
RU2007129578A (en) METHOD FOR INTEGRATED TREATMENT OF ACUTE-pointed URGENITAL TRACT
RU2012153105A (en) METHOD FOR GROWING YOUNG PIG
RU2009124823A (en) METHOD FOR TREATING A PATIENT WITH CHRONIC Brucellosis
EA201491652A1 (en) MEANS FOR TREATING VIRAL HEPATITIS C
RU2013143983A (en) METHOD OF CORRECTION OF IMMUNE DEFICIENCY IN CATTLE LEUKEMIS VIRUS INFECTED
RU2010140179A (en) METHOD FOR TREATING PERIODONTITIS - METHOD OF JORDANISHVILI
MY151564A (en) Intravenous pharmaceutical composition to enhance immunity for the treatment of viral infections
UA58066U (en) Method for treating genital viral infection
RU2012130292A (en) METHOD FOR DIAGNOSIS OF PAIN IMPULSATION IN PATIENTS WITH COMBINED DEGENERATIVE-DYSTROPHIC DEFRACTION OF KNEE, HIP JOINTS AND SPINE (COMPLEX KNEE-HIP-SPINE SYNDROME)
RU2012128821A (en) METHOD FOR TREATING INFLUENZA AND INFLUENZAID DISEASES COMPLICATED BY PNEUMONIA
UA69260U (en) method for treatment of chronic bronchitis in patients with combined course with peptic duodenal ulcer
UA58749U (en) method for treatment of hepatic steatosis in patients with tuberculosis

Legal Events

Date Code Title Description
PC41 Official registration of the transfer of exclusive right

Effective date: 20170306

QB4A Licence on use of patent

Free format text: LICENCE

Effective date: 20170505